Cashu
Takeda's Adzynma Faces FDA Scrutiny Over Safety Concerns and Neutralizing Antibodies
14 days ago
Stocks
Health Care
tak
Takeda Pharmaceutical Company
TOKYO STOCK EXCHANGE-TOKYO PRO MARKET: TAK
-0.09 (-0.63%)
14.19
USD
At close at Dec 05, 21:37 UTC
Overview
Loading chart...
Key Stats
Market Cap
44.96B
Dividend Yield
0.00%
P/E Ratio
8.74
EPS
0.44
Revenue
30.18B
Avg. Volume
2.29M
About
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.